CHEPLAPHARM Adopts TraceLink MINT to Digitalize Global Supply Chain
CHEPLAPHARM is implementing the Multienterprise Information Network Tower (MINT) from TraceLink to unify and digitalize its global supply chain operations, announced in a press release. The German pharmaceutical company will use MINT, powered by the Orchestration Platform for Universal Solutions (OPUS), to automate key workflows and improve data exchange with its international partners.
The MINT platform will allow CHEPLAPHARM to exchange operational data such as purchase orders, delivery updates, and shipment notifications directly between enterprise systems. This move replaces manual processes that relied on emails and spreadsheets, aiming to reduce administrative workloads and increase transparency across its network.
CHEPLAPHARM selected TraceLink for its Integrate-Once model, which enables rapid partner onboarding through a single network connection without additional cost to partners. The system standardizes data exchange between CHEPLAPHARM’s SAP environment and the diverse ERP systems used by its global suppliers, minimizing customization and reducing IT complexity.
The company expects the implementation to strengthen operational resilience and provide a foundation for future use of agent-based intelligence within supply chain management.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 Nvidia invested in a record 121 startup funding rounds in 2026, Crunchbase data shows Nov 13 KeyBanc survey: AI-native software grows faster but loses more money Nov 13 PangeAI signs Sky Blue Impact to speed up data centre site analysis Nov 13 Druva launches backup and recovery for Copilot Studio AI agents Nov 13 Redesign Health launches growth equity practice for clinical AIMore from Life Sciences
Nov 13 Machine-learning models predict death risk after heart attack better than standard score Nov 13 Redesign Health launches growth equity practice for clinical AI Nov 13 Dyania Health and Nvidia bring clinical reasoning AI inside hospital networks Nov 13 Betterness extends seed round to $3.5M for Miami AI health networks Nov 13 93% of health systems now use AI, CHIME survey findsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Mintive raises $7 million for enterprise AI agent access controls
Catalyx Launches OpenLine Manufacturing Control Platform
Plinto Raises €2.9 Million for AI Financial Controls
Mind Lab Opens Mint Recursive AI Training Platform to Enterprises
Munich's SPARETECH raises $20 million Series B to cut factories' spare-parts inventory with AI
Daily AI Brief: the AI news that matters, in your inbox.